Study Finds Most Part D Generic Drugs Are Now On Non-Generic Tiers

By Ariel Cohen / February 14, 2020 at 5:00 PM

For the first time in the history of Medicare Part D, generic drugs make up a bigger share of non-preferred formulary tiers where they cost more, which discourages consumers from choosing generics, according to a new analysis from Avalere.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.